Thomas Woiwode
CIK 1619294 · last filed 2023-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.28M
Companies
8
Total Filings
49
Lifetime Open-Market Net
-$7.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 35,418 | $4.57 | $161.9K | $4.05M | 5 | 2023-05-26 |
| ALGS | Director | 58,495 | $4.25 | $248.6K | $3.00M | 5 | 2022-06-27 |
| TPST | Director | 180,168 | $0.87 | $156.9K | $5.00M | 5 | 2022-06-22 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 6,740 | $0.03 | $217 | $5.00M | 5 | 2021-08-27 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 1,882 | $4.36 | $8.2K | $0 | 14 | 2021-05-14 |
| CRSP | Director | 645,643 | $47.55 | $30.70M | -$27.67M | 7 | 2018-06-15 |
| CRISPR Therapeutics AG (PZRX) Delisted | Director | 4,959 | — | — | $2.15M | 6 | 2017-12-27 |
| BOLD | Director | 6,811 | $2.47 | $16.8K | $525.0K | 2 | 2016-08-25 |
Recent Filings · Page 2 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-15 | ALGS | Other (J) | −483,753 | $0 | EDGAR |
| 2021-05-28 | PASG | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-28 | ALGS | Other (J) | −483,753 | $0 | EDGAR |
| 2021-01-04 | Gritstone bio, Inc. (GRTS) Delisted | Buy (P) | +1,347,709 | $5.00M | EDGAR |
| 2020-12-16 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Other (J) | +12,783 | $0 | EDGAR |
| 2020-10-20 | ALGS | Mixed | +3,292,339 | $3.00M | EDGAR |
| 2020-06-25 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-22 | Gritstone bio, Inc. (GRTS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-03 | PASG | Mixed | +4,959,769 | $4.05M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.